PT99249A - Processo para a preparacao de derivados de piperazina - Google Patents

Processo para a preparacao de derivados de piperazina

Info

Publication number
PT99249A
PT99249A PT99249A PT9924991A PT99249A PT 99249 A PT99249 A PT 99249A PT 99249 A PT99249 A PT 99249A PT 9924991 A PT9924991 A PT 9924991A PT 99249 A PT99249 A PT 99249A
Authority
PT
Portugal
Prior art keywords
preparation
piperazine derivatives
piperazine
derivatives
Prior art date
Application number
PT99249A
Other languages
English (en)
Other versions
PT99249B (pt
Inventor
Alan Chapman White
Ian Anthony Cliffe
Anderson Decourtney Ifill
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth John & Brother Ltd filed Critical Wyeth John & Brother Ltd
Publication of PT99249A publication Critical patent/PT99249A/pt
Publication of PT99249B publication Critical patent/PT99249B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/18—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carboxylic acids, or sulfur or nitrogen analogues thereof
    • C07D295/182—Radicals derived from carboxylic acids
    • C07D295/185—Radicals derived from carboxylic acids from aliphatic carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/56—Amides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
PT99249A 1990-10-19 1991-10-17 Processo para a preparacao de derivados de piperazina PT99249B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909022790A GB9022790D0 (en) 1990-10-19 1990-10-19 Piperazine derivatives

Publications (2)

Publication Number Publication Date
PT99249A true PT99249A (pt) 1992-08-31
PT99249B PT99249B (pt) 1999-04-30

Family

ID=10684033

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99249A PT99249B (pt) 1990-10-19 1991-10-17 Processo para a preparacao de derivados de piperazina

Country Status (10)

Country Link
US (1) US5369103A (pt)
EP (2) EP1123926A1 (pt)
JP (1) JP3090683B2 (pt)
KR (1) KR100201192B1 (pt)
CA (1) CA2071940A1 (pt)
GB (2) GB9022790D0 (pt)
IE (1) IE65641B1 (pt)
NZ (1) NZ240273A (pt)
PT (1) PT99249B (pt)
WO (1) WO1992006960A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9125900D0 (en) * 1991-12-05 1992-02-05 Wyeth John & Brother Ltd Piperazine derivatives
HUT71899A (en) * 1992-08-05 1996-02-28 Wyeth John & Brother Ltd Amide derivatives, pharmaceutical compositions containing them and process for producing them
GB9314758D0 (en) * 1993-07-16 1993-08-25 Wyeth John & Brother Ltd Heterocyclic derivatives
US5609849A (en) * 1994-03-11 1997-03-11 The Trustees Of The University Of Pennsylvania Serotonin (5-HT1A) receptor ligands and imaging agents
US5434158A (en) * 1994-04-26 1995-07-18 Merck & Co., Inc. Spiro-substituted azacycles as neurokinin-3 antagonists
CN101496802B (zh) 2008-01-31 2011-04-27 江苏恩华药业股份有限公司 芳基哌嗪衍生物在制备治疗疼痛药物方面的用途
WO2012021144A1 (en) 2010-08-12 2012-02-16 New York University Oligooxopiperazines and methods of making and using them
CN105246481A (zh) 2013-01-19 2016-01-13 纽约大学 用于p53再活化的低聚氧代哌嗪
WO2015160914A1 (en) 2014-04-15 2015-10-22 New York University OXOPIPERAZINE HELIX MIMETICS AS INHIBITORS OF THE p53-MDM2 INTERACTION

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE630835A (pt) * 1962-04-16
GB2227018B (en) * 1989-01-13 1992-05-20 Wyeth John & Brother Ltd Piperazinylalkylcarboxylic acid adamantylamides
GB8909209D0 (en) * 1989-04-22 1989-06-07 Wyeth John & Brother Ltd Piperazine derivatives
IE950248L (en) * 1989-04-22 1990-10-22 Wyeth John & Brother Ltd Piperazine derivatives
GB9022821D0 (en) * 1990-10-19 1990-12-05 Wyeth John & Brother Ltd Piperazine derivatives

Also Published As

Publication number Publication date
GB2248837A (en) 1992-04-22
JP3090683B2 (ja) 2000-09-25
PT99249B (pt) 1999-04-30
GB9022790D0 (en) 1990-12-05
GB9121945D0 (en) 1991-11-27
IE65641B1 (en) 1995-11-15
WO1992006960A1 (en) 1992-04-30
US5369103A (en) 1994-11-29
GB2248837B (en) 1994-05-04
KR927003533A (ko) 1992-12-18
JPH05502897A (ja) 1993-05-20
NZ240273A (en) 1992-10-28
EP1123926A1 (en) 2001-08-16
EP0506905A1 (en) 1992-10-07
CA2071940A1 (en) 1992-04-20
KR100201192B1 (ko) 1999-06-15
IE913667A1 (en) 1992-04-22

Similar Documents

Publication Publication Date Title
PT90619A (pt) Processo para a preparacao de compostos de piperazina
PT98638A (pt) Processo para a preparacao de derivados de borsolina
PT97433A (pt) Processo para a preparacao de sacarose-6-ester
PT93785A (pt) Processo para a preparacao de derivados de 3-substituido-2-oxindole
PT98717A (pt) Processo para a preparacao de derivados de pirazole
PT98491A (pt) Processo para a preparacao de um poliactideo
PT89205A (pt) Processo para a preparacao de derivados de indano
PT84561B (pt) Processo aperfeicoado para a preparacao de derivados macrolidos
PT97886A (pt) Processo para a preparacao de extractos de cha
PT91895A (pt) Processo para a preparacao de 9h-purinas substituidas
PT90914A (pt) Processo para a preparacao de derivados de benzazepinae benzotiazapina
PT89922A (pt) Processo para a preparacao de derivados da tiazolidenodiona
PT89545A (pt) Processo para a preparacao de derivados da isoquinolinona
PT90266A (pt) Processo para a preparacao de compostos azabiciclicos
PT88181A (pt) Processo para a preparacao de derivados aralquilaminoalcoxifenilo
PT93629A (pt) Processo para a preparacao de derivados de tieno-triazolo-diazepina
PT89775A (pt) Processo para a preparacao de derivados de isoquinolina
PT91027A (pt) Processo para a preparacao de derivados peptidicos
PT92539A (pt) Processo para a preparacao de derivados de anfotericina b
PT94008A (pt) Processo para a preparacao de novos derivados de tieno-triazolo-diazepina
PT97828A (pt) Processo para a preparacao de fenil-triazinas
PT93033A (pt) Processo para a preparacao de derivados de guanidina
BR8202085A (pt) Processo para a preparacao de derivados de piperazina
PT88924A (pt) Processo para a preparacao de derivados de ginkgolidos
PT93631A (pt) Processo para a preparacao de derivados de tieno-triazolo-diazepina

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920422

FG3A Patent granted, date of granting

Effective date: 19990107